The Differences in Functional Recovery Between HIV-positive and HIV-negative Stroke Survivors
Overview
Affiliations
Objectives: This study aims to identify the differences in functional abilities between stroke survivors who are human immunodeficiency virus (HIV)-positive and HIV-negative.
Patients And Methods: This was a retrospective, longitudinal record review of stroke survivors' files between April 2005 and December 2010. Of a total of 173 stroke survivors who were admitted to the rehabilitation unit, 141 (75 males, 66 females; mean age 52.7±14.3 years; range, 19 to 86 years) met the inclusion criteria. The patients were divided into two groups as HIV-positive (n=21) and HIV-negative (n=120). Functional ability was recorded using the admission and discharge BETA® scores.
Results: Ischemic strokes were more prevalent than hemorrhagic strokes (74.5% vs. 25.5%, respectively) with hypertension as the most common (31.9%) stroke risk factor. The mean age of stroke onset for HIV-positive patients and HIV-negative patients was 39.6 years and 54.9 years, respectively. In HIV-positive patients, the mean duration of rehabilitation was 7.5-day shorter than HIV-negative patients. After receiving rehabilitation from a multidisciplinary team, the HIV-positive group improved with a mean of 40 points and the HIV-negative group improved with a mean of 38 points. The similarities in functional outcome between the HIV-positive and HIV-negative group were related to the fact that HIV-positive stroke survivors were relatively younger than the HIV-negative group.
Conclusion: Our study results show that patients who sustain a stroke, are HIV-positive, are receiving antiretroviral therapy and rehabilita- tion may recover similar to those who are HIV-negative, spending a similar length of stay in a rehabilitation clinic. Therefore, stroke survivors who are HIV-positive should receive full rehabilitation similar to any other stroke survivors.
Fattakhov N, Ngo A, Torices S, Joseph J, Okoro A, Moore C Am J Physiol Cell Physiol. 2023; 326(2):C487-C504.
PMID: 38145295 PMC: 11192487. DOI: 10.1152/ajpcell.00600.2023.
Corbett C, Brey N, Pitcher R, OHagan S, Esterhuizen T, Chow F Neurology. 2022; 99(9):e904-e915.
PMID: 36038281 PMC: 9502736. DOI: 10.1212/WNL.0000000000200780.
Kuate L, Tchuisseu L, Jingi A, Kouanfack C, Endomba F, Ouankou C Pan Afr Med J. 2021; 40:8.
PMID: 34650658 PMC: 8490168. DOI: 10.11604/pamj.2021.40.8.30855.
Hartley T, Burger M, Esterhuizen T, Inglis-Jassiem G Afr J Disabil. 2020; 9:618.
PMID: 32284924 PMC: 7136685. DOI: 10.4102/ajod.v9i0.618.